Profil
Karine Lignel is the founder of Oncodesign Precision Medicine SA, founded in 2020, holding the titles of Chief Operating Officer, Director & Deputy MD.
Current jobs include Chairman at Société Financière Aquitaine De Participation; Investment Director at CM-CIC Innovation SASU since 2011; Director, Group Chief Development Officer & SVP at Oncodesign SA since 2021; and Director at SILIOS Technologies SA. Former jobs include Director at Ariana Pharmaceuticals SA, Amorçage Rhône-Alpes SAS as Investment Director, Sartorius Polyplus SAS, Confederation Nationale Crédit Mutuel SA, EndoControl SAS, ImmunID SAS, e(ye) Brain SA, Tissium SA, Maat Pharma SA, Krono-Safe SA; Non-Voting Director at Voluntis SA; Director at Global Bioenergies SA from 2013 to 2020; Member-Supervisory Board at Coldway SA, Rhones Alpes Creation, Nanobiotix SA, MedinCell SA, and ForCity SAS. Education includes an MBA from ESSEC Business School and undergraduate studies at Ecole Superieure des Industries Agricoles et Alimentaires.
Postes actifs de Karine Lignel
| Sociétés | Poste | Début |
|---|---|---|
| ONCODESIGN | Directeur/Membre du Conseil | 14/05/2008 |
| ONCODESIGN PRECISION MEDICINE | Fondateur | 15/12/2020 |
CM-CIC Innovation SASU
CM-CIC Innovation SASU Investment ManagersFinance CM-CIC Innovation invests in companies located in France. The firm targets companies operating in deeptech, software & IT and health sectors. It provides financing for early stage transactions, It acts as a lead investor. | Director of Investments | 08/12/2009 |
Société Financière Aquitaine De Participation
Société Financière Aquitaine De Participation Financial ConglomeratesFinance Functions as an investment holding company | Président | - |
SILIOS Technologies SA
SILIOS Technologies SA Electronic ComponentsElectronic Technology Manufactures optical miniature parts | Directeur/Membre du Conseil | - |
Anciens postes connus de Karine Lignel
| Sociétés | Poste | Fin |
|---|---|---|
| GLOBAL BIOENERGIES SA | Directeur/Membre du Conseil | 01/03/2020 |
| NANOBIOTIX | Directeur/Membre du Conseil | - |
Polyplus-transfection SA
Polyplus-transfection SA BiotechnologyHealth Technology Provides cell and gene therapy services | Directeur/Membre du Conseil | - |
ImmunID SAS
ImmunID SAS Medical SpecialtiesHealth Technology Researches and develops diagnostic tools for monitoring immune cell repertoire | Directeur/Membre du Conseil | - |
| ░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Karine Lignel
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 24 |
|---|---|
Ariana Pharmaceuticals SA
Ariana Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Provides pharmaceutical, clinical and data technology | Health Technology |
ESSEC Business School
ESSEC Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CM-CIC Innovation SASU
CM-CIC Innovation SASU Investment ManagersFinance CM-CIC Innovation invests in companies located in France. The firm targets companies operating in deeptech, software & IT and health sectors. It provides financing for early stage transactions, It acts as a lead investor. | Finance |
Amorçage Rhône-Alpes SAS
Amorçage Rhône-Alpes SAS Investment ManagersFinance ARA is an active manager which invests in innovative French technology companies with high growth potential in a range of sectors including biotechnology, information technology and telecom, medical technology, nanotechnology and environment. The firm seeks to invest EUR 50,000-200,000 in companies which are either in their creation stage or have been in operation for less than two years, which are based in the administrative territory of the Rhone-Alpes region and which have technology originating from, or being developed in cooperation with a French public research institution. ARA usually co-invests with other financing partners and typically expects to exit their investments after three to seven years. The firm's investment committee makes the investment decisions. | Finance |
Coldway SA
Coldway SA Wholesale DistributorsDistribution Services Manufactures refrigerated and insulated containers | Distribution Services |
Oncodesign SA
Oncodesign SA BiotechnologyHealth Technology Develops preclinical evaluation of novel anticancer therapies | Health Technology |
Polyplus-transfection SA
Polyplus-transfection SA BiotechnologyHealth Technology Provides cell and gene therapy services | Health Technology |
Confederation Nationale Crédit Mutuel SA
Confederation Nationale Crédit Mutuel SA Major BanksFinance Provides cooperative banking services | Finance |
Rhones Alpes Creation | |
EndoControl SAS
EndoControl SAS Medical SpecialtiesHealth Technology Designs, develops and markets robotics solutions for laparoscopic surgeries | Health Technology |
Nanobiotix SA
Nanobiotix SA Pharmaceuticals: MajorHealth Technology Develops and manufactures nanotherapeutics for treatment of cancer | Health Technology |
Ecole Superieure des Industries Agricoles et Alimentaires
Ecole Superieure des Industries Agricoles et Alimentaires Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Voluntis SA
Voluntis SA Packaged SoftwareTechnology Services Develops anti-cancer treatment platform | Technology Services |
SILIOS Technologies SA
SILIOS Technologies SA Electronic ComponentsElectronic Technology Manufactures optical miniature parts | Electronic Technology |
ImmunID SAS
ImmunID SAS Medical SpecialtiesHealth Technology Researches and develops diagnostic tools for monitoring immune cell repertoire | Health Technology |
e(ye) Brain SA
e(ye) Brain SA Medical DistributorsDistribution Services Provides medical research services | Distribution Services |
Global Bioenergies SA
Global Bioenergies SA Chemicals: SpecialtyProcess Industries Develops industrial processes to convert renewable sources into hydrocarbons through fermentation | Process Industries |
MedinCell SA
MedinCell SA Pharmaceuticals: MajorHealth Technology Provides therapeutic solutions | Health Technology |
Krono-Safe SA
Krono-Safe SA Packaged SoftwareTechnology Services Provides software solutions for the development of embedded systems | Technology Services |
Tissium SA
Tissium SA BiotechnologyHealth Technology Develops biomorphic and programmable polymers for tissue reconstruction | Health Technology |
Maat Pharma SA
Maat Pharma SA Pharmaceuticals: MajorHealth Technology Operates as a clinical stage company which develops and commercializes patient-microbiome symbiosis to improve survival outcomes in oncology | Health Technology |
ForCity SAS
ForCity SAS Miscellaneous Commercial ServicesCommercial Services Provides support services to the decision for the actors public and economic territories | Commercial Services |
Société Financière Aquitaine De Participation
Société Financière Aquitaine De Participation Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Oncodesign Precision Medicine SA
Oncodesign Precision Medicine SA Pharmaceuticals: MajorHealth Technology Discovers and develops new molecules for the health treatments in oncology | Health Technology |
















